Adalimumab: Injection 40 mg in 0.8 ml pre-filled syringe, 2; Injection 40 mg in 0.8 ml pre-filled pen, 2; Injection 40 mg in 0.8 ml pre-filled syringe, 6; Injection 40 mg in 0.8 ml pre-filled pen, 6; Hyrimoz®

Page last updated: 3 July 2020

• Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
• Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)